Asunto(s)
Neoplasias Cardíacas/diagnóstico , Leucemia/diagnóstico , Sarcoma Mieloide/diagnóstico , Procedimientos Quirúrgicos Cardíacos/métodos , Diagnóstico Diferencial , Ecocardiografía , Femenino , Atrios Cardíacos , Neoplasias Cardíacas/complicaciones , Neoplasias Cardíacas/cirugía , Humanos , Leucemia/complicaciones , Imagen por Resonancia Cinemagnética , Persona de Mediana Edad , Sarcoma Mieloide/complicaciones , Sarcoma Mieloide/cirugía , Tomografía Computarizada por Rayos XRESUMEN
PURPOSE OF REVIEW: In light of all the recent controversy regarding the use of synthetic mesh for pelvic organ prolapse, we did a retrospective review of the evidence-based outcomes and complications for its use. RECENT FINDINGS: A total of 18 of the most recent studies in the last 5 years were selected. Studies selected were prospective randomized or quasi-randomized controlled trials that included surgical operations for pelvic organ prolapse for this review. Additionally, Cochrane review and meta-analysis of outcomes and complication were also analyzed. In terms of outcomes, the definition of successful surgery is currently being debated. Synthetic mesh provides superior anatomical and subjective cure rates compared with native tissue repair. Success rates varied greatly depending on the nature of prolapse and surgical approach. Furthermore, recurrence rates for mesh-based surgery are significantly lower than that for native tissue repair. The main unique complication of mesh is exposure and was reported in a mean of 11.4% of patients, with 6.8% of patients requiring surgical partial excision of mesh. SUMMARY: Mesh significantly improves anatomical outcomes with sacrocolpopexy and vaginal repair. Mesh does create the unique complication which can be reduced with training and proper patient selection. Further development of better materials is vital rather than reverting to tissue-based repair. Ultimately, the decision to use mesh should be based upon a patient's personal goals and preferences after an informed conversation with her physician.
Asunto(s)
Prolapso de Órgano Pélvico/cirugía , Mallas Quirúrgicas/efectos adversos , Humanos , Incidencia , Prolapso de Órgano Pélvico/epidemiología , Prevalencia , Resultado del TratamientoRESUMEN
Liver disease is an important and serious condition in pregnancy. The Confidential Enquiries Into Maternal Deaths in Malaysia showed that there were 23 maternal deaths attributed to liver disease between 1991-1994. Over the same period, there were 1066 reported maternal deaths with 929 of them being due to direct and indirect causes. Thus 2.15% of such deaths were due to liver disease in Malaysia. The three main causes of maternal deaths due to liver disease in pregnancy were hepatitis (6 cases), acute fatty liver in pregnancy (6 cases) and septicaemia (4 cases). Liver disease is common at a mean of thirty weeks of gestation with a preponderance to women of low parity. Only two patients in this series had no antenatal care. The majority of cases (45.8%) presented between 28-37 weeks of gestation. All cases delivered by spontaneous vaginal delivery. Remediable factors that were identified included failure to appreciate the severity of disease. Case summaries of all the cases of maternal deaths due to liver disease are discussed and a guideline to management of liver disease in pregnancy presented.